FREMONT, CA -- (Marketwire) -- 10/27/08 -- Cardima, Inc. (OTCBB: CADM), a medical device company focused on the treatment of Atrial Fibrillation ("AF") and manufacturer of the Cardima Surgical Ablation System, the EP Ablation System, and the PATHFINDER® family of diagnostic microcatheters, is pleased to announce the establishment of its Surgical Ablation Training Program and Center of Excellence at Stamford Hospital, Stamford, Connecticut, for the Cardima Surgical Ablation System. Stamford Hospital is an internationally recognized teaching hospital that maintains an educational partnership with the Columbia University College of Physicians and Surgeons, New York, New York.

Dr. Li Poa, Chief of Cardiothoracic Surgery and Cardiac Surgery Program Director at Stamford Hospital and faculty member of Columbia University, is one of the world's leading authorities on surgical ablation for the treatment of Atrial Fibrillation (AF). Dr. Li Poa will head the Cardima Center of Excellence Program at Stamford Hospital. He has conducted extensive work perfecting thorascopic surgical techniques, and will train cardiothoracic surgeons on using the Cardima Surgical Ablation System.

Stamford Hospital and the surgical team led by Dr. Li Poa will provide cardiothoracic surgeons with an opportunity to expand their practice using the Cardima Surgical Ablation System. This training will allow these new hospitals to offer their community a successful treatment option for Atrial Fibrillation. As Cardima expands in the USA surgical market, as well as globally into select markets, additional Training Programs and Centers of Excellence will be established in strategic geographic areas.

Dr. Li Poa commented: "Based on our experience at Stamford Hospital using Cardima's Surgical Ablation System, we have established that the Cardima system is capable of creating a fairly complete complex lesion set for the minimally invasive surgical treatment of lone AF with the establishment of both pulmonary vein and antral isolation, ablation of the right sided gangliae and posterior inferior vena cava, and a crossing closed loop lesion of the coronary sinus isthmus. The Cardima system has been shown to reliably and reproducibly establish both entrance conduction block and exit conduction block in its pulmonary vein isolation series. This is a very important development for achieving effective long-term results. The Cardima system can create continuous transmural lesions, without gaps and can be easily manipulated to create all the necessary lesions for a full surgical procedure. The entire AF ablation procedure can be completed rapidly using the least invasive approach for epicardial ablation via a unilateral two-port thorascopic approach.